滑板鞋20202018-10-21 12:25
$德纳维制药(DVAX)$ Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab) ****Continues***** to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at the ESMO 2018 Congress
esmo: c1/2mg, 1-4 lesions, 33/47, 70%; c2/8...查看全文
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001104659-16-096141 Size: 70 KB 网页链接
$Dyax(DYAX)$ EFFECT - Notice of Effectiveness Filed: 2016-02-10 AccNo: 9999999995-16-003718 Size: 1 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001623632-16-002292 Size: 103 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-08 AccNo: 0001623632-16-002288 Size: 105 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-05 AccNo: 9999999997-16-016575 Size: 10 KB 网页链接
$Dyax(DYAX)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2016-02-01 AccNo: 0001104659-16-092917 Size: 23 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-01 AccNo: 9999999997-16-016468 Size: 10 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-26 AccNo: 0000215457-16-002509 Size: 13 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091049 Size: 43 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091048 Size: 43 KB 网页链接